Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rigliti phosphate + metformin in type 2 diabetes
CTR20192383Phase 2Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of retagliptin in type 2 diabetes mellitus (T2DM), sponsored by Hengrui Therapeutics. Started Nov 2019; status: completed.
02
Drugs
retagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20192383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192383.